Last updated: 20 July 2019 at 8:44pm EST

Roger Hawley Net Worth




The estimated Net Worth of Roger Hawley is at least $7.14 million dollars as of 11 April 2019. Roger Hawley owns over 454,545 units of Dare Bioscience Inc stock worth over $3,080,557 and over the last 14 years Roger sold DARE stock worth over $4,059,064.

Roger Hawley DARE stock SEC Form 4 insiders trading

Roger has made over 13 trades of the Dare Bioscience Inc stock since 2010, according to the Form 4 filled with the SEC. Most recently Roger bought 454,545 units of DARE stock worth $500,000 on 11 April 2019.

The largest trade Roger's ever made was buying 454,545 units of Dare Bioscience Inc stock on 11 April 2019 worth over $500,000. On average, Roger trades about 34,678 units every 109 days since 2010. As of 11 April 2019 Roger still owns at least 944,956 units of Dare Bioscience Inc stock.

You can see the complete history of Roger Hawley stock trades at the bottom of the page.



What's Roger Hawley's mailing address?

Roger's mailing address filed with the SEC is C/O ZOGENIX, INC., 12671 HIGH BLUFF DR., SUITE 200, SAN DIEGO, CA, 92130.

Insiders trading at Dare Bioscience Inc

Over the last 7 years, insiders at Dare Bioscience Inc have traded over $0 worth of Dare Bioscience Inc stock and bought 594,545 units worth $703,000 . The most active insiders traders include William H Rastetter, Roger Hawley et Cheryl R Blanchard. On average, Dare Bioscience Inc executives and independent directors trade stock every 152 days with the average trade being worth of $969,110. The most recent stock trade was executed by Roger Hawley on 11 April 2019, trading 454,545 units of DARE stock currently worth $500,000.



What does Dare Bioscience Inc do?

daré bioscience (nasdaq: dare) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s reproductive health. we are driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. we are initially focused on the areas of contraception, vaginal health and fertility. our lead product candidate, ovaprene, is a non-hormonal, monthly contraceptive ring that is currently in clinical studies.



Complete history of Roger Hawley stock trades at Zogenix Inc et Dare Bioscience Inc

Initié
Trans.
Transaction
Prix ​​total
Roger Hawley
Directeur
Acheter $500,000
11 Apr 2019
Roger Hawley
Directeur
Acheter $203,000
11 Jun 2018
Roger Hawley
Chief Executive Officer
Exercice d'option $632,592
29 Mar 2019
Roger Hawley
Chief Executive Officer
Vente $3,179,400
13 Mar 2019
Roger Hawley
Chief Executive Officer
Exercice d'option $139,836
1 Mar 2019
Roger Hawley
Chief Executive Officer
Vente $827,000
14 Dec 2018
Roger Hawley
Chief Executive Officer
Exercice d'option $652,050
12 Mar 2018
Roger Hawley
Chief Executive Officer
Exercice d'option $1,719,633
7 Dec 2017
Roger Hawley
Chief Executive Officer
Acheter $137,400
15 Dec 2015
Roger Hawley
Chief Executive Officer
Acheter $137,400
15 Dec 2015
Roger Hawley
Chief Executive Officer
Vente $52,664
2 Jun 2014
Roger Hawley
Chief Executive Officer
Acheter $100,000
21 Sep 2011
Roger Hawley
Chief Executive Officer
Acheter $55,300
6 Dec 2010


Dare Bioscience Inc executives and stock owners

Dare Bioscience Inc executives and other stock owners filed with the SEC include: